How Far Have We Developed Antibody-Drug Conjugate for the Treatment of Cancer?
Cancer, also known as malignant tumour or neoplasm, is a leading cause of death worldwide. One distinct feature from normal cells is that cancerous cells often overexpress protein on the cell membrane-for instance, the overexpression of human epidermal growth factor receptor 2. The expression of a s...
Saved in:
Main Authors: | Yu Jun Lim (Author), Pei Sze Clarissa Lau (Author), Shi Xuan Low (Author), Shong Li Ng (Author), Min Yee Ong (Author), Huey Ming Pang (Author), Zheng Yang Lee (Author), Hui Yin Yow (Author), Sharina Binti Hamzah (Author), Renukha Sellappans (Author), Jhi Biau Foo (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging Nanotheranostics for 5-Fluorouracil in Cancer Therapy: A Systematic Review on Efficacy, Safety, and Diagnostic Capability
by: Chee Wun How, et al.
Published: (2022) -
Taking a Step Further in Identifying Ideal Blood Pressure Range Among Hemodialysis Patients: A Systematic Review and a Meta-Analysis
by: Raja Ahsan Aftab, et al.
Published: (2020) -
Small Extracellular Vesicles' miRNAs: Biomarkers and Therapeutics for Neurodegenerative Diseases
by: Wei Qing Lim, et al.
Published: (2023) -
Mesenchymal Stem Cell-Derived Exosomes and MicroRNAs in Cartilage Regeneration: Biogenesis, Efficacy, miRNA Enrichment and Delivery
by: Jhi Biau Foo, et al.
Published: (2021) -
A step too far? Making health equity interventions in Namibia more sufficient
by: Ithindi Taati, et al.
Published: (2003)